U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06804057) titled 'CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry' on Dec. 02, 2024.
Brief Summary: Prospective, observational registry for subjects with SLE under the care of a rheumatology provider. Longitudinal data are collected from both subjects and their treating rheumatology provider during routine clinical encounters using a structured and standardized data collection method.
Study Start Date: Sept. 26, 2024
Study Type: OBSERVATIONAL
Condition:
Systemic Lupus Erythematosus
Intervention:
OTHER: Blood Collection
Blood will be collected for the subjects who are willing to participate in the optional bio...